Compare UiPath Inc (PATH) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UiPath Inc vs UnitedHealth Group Inc — how do they compare? UiPath Inc trades at $13.26 (market cap $6.81B), while UnitedHealth Group Inc trades at $370.65 (market cap $337.48B). The key difference: UnitedHealth Group Inc is far larger — about 49.6× UiPath Inc's market cap, and UnitedHealth Group Inc pays a 2.47% dividend while UiPath Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold UiPath Inc for 139 Days and UnitedHealth Group Inc for 97 Days on average.
| PATH | UNH | |
|---|---|---|
Market Cap | $6.81B | $337.48B |
Volume | 22,766,109 | 5,620,541 |
Sector | Technology | Health |
52-Week High | $19.29 | $436.35 |
52-Week Low | $9.38 | $259.02 |
Typical Hold Time | 139 Days | 97 Days |
Enterprise Value | $5.61B | $379.34B |
Dividend Yield | — | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
UiPath (PATH) trades at $13.25, up 1.15% with mixed technical signals showing bearish momentum but neutral oscillators. The company demonstrates improving fundamentals with revenue growing from $1.43B in 2025 to projected $1.7B in 2026, while transitioning from net losses to profitability. Recent partnerships with Snowflake and BDO highlight strategic positioning in AI automation, though the stock faces near-term headwinds from valuation concerns and competitive pressures.
PATH presents a turnaround story with strong revenue growth and path to profitability, but faces execution risks amid competitive automation landscape. The consensus price target of $15.13 suggests 14% upside potential, though technical weakness and mixed analyst sentiment warrant caution. Key catalysts include AI platform adoption and enterprise expansion, while risks involve growth sustainability and margin pressures.
UnitedHealth Group (UNH) trades at $370.95, down 1.43% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats and a raised 2026 outlook highlight fundamental strength, though net income margins have compressed. The stock is supported by a $2.32 dividend payment scheduled for September 22, 2026, and positive sentiment around Medicare Advantage and Optum growth.
The outlook remains positive with an 82.7% analyst buy rating and a $473.89 consensus price target, implying significant upside. Key risks include regulatory pressures and medical cost trends, but strategic AI investments and solid cash flow support long-term growth. Investors should weigh the attractive valuation against execution risks in a dynamic healthcare landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UiPath Inc
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
